Ziv Carmon (Hebrew: זיו כרמון) is the Dean of Research, Professor of Business Administration, and holder of The Alfred H. Heineken Chaired Professorship at INSEAD.

[4] After working in sales and business analysis in the corporate world, he studied in the United States at University of California at Berkeley, where he received his MS in Business Administration and his PhD with a thesis entitled The Contingent Nature of Consumers Assessments of the Quality of Products and Services under the guidance of Nobel Laureate Daniel Kahneman and Itamar Simonson.

His views on business frequently appear in international media outlets such as: New York Times, The Washington Post, Los Angeles Times, The New Yorker, Forbes, The Wall Street Journal, Financial Times, Scientific American, Popular Science, Bloomberg Businessweek, Newsweek, USA Today, The Huffington Post, The Boston Globe, International Herald Tribune, Marketing News, The Times (UK), The Guardian (UK), The Daily Telegraph (UK), Toronto Star, Newsweek, National Public Radio, MSNBC, ABC News, Channel 4 (UK), and numerous blogs.

[15] His papers on Indeterminacy and the Live TV, and on Option Attachment, were finalists for the 2009 and 2006 Journal of Consumer Research Best Article Awards.

In 2008 Carmon, along with his co-authors, Rebecca Waber, Dan Ariely and Baba Shiv, was awarded an Ig Nobel Prize in medicine for their research demonstrating that high-priced placebos are more effective than low-priced ones.